НовостиBenzingaSeaport Therapeutics To Present Phase 1 Clinical Data For GlyphAgo At The European College Of Neuropsychopharmacology Congress, October 10-13 Seaport Therapeutics To Present Phase 1 Clinical Data For GlyphAgo At The European College Of Neuropsychopharmacology Congress, October 10-13 Benzinga 2026.10.09 11:22 (GMT+0) Открыть на Benzinga Другие новости